Tominersen clinical trials

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

This study, GENERATION HD2, is looking at a new drug called tominersen for Huntington's disease. Researchers want to see how safe it is, how it affects the body, and if it helps people in the early stages of the condition. It's comparing tominersen to a dummy drug.